Complete medical history, including •Past medical history, especially heart, lung, liver or renal disease, and diabetes mellitus (comorbidity score) •Family history •Occupational history Complete physical examination, with special attention to…
Fig. 15.1 US acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) incidence rates (age-adjusted, 2000 US standard) by race and sex, diagnosed among residents of nine cancer registry areas…
4. Pearson OH, Eliel LP, Rawson RW, et al. ACTH- and cortisone-induced regression of lymphoid tumors in man. Cancer. 1949;2:943–5.PubMed
CrossRef 3. Piller G. The history of leukemia: a personal perspective. Blood Cells. 1993;19:521.PubMed 4. Velpeau A. Sur la resorption du puseat sur l’altération du sang dans les maladies clinique…
Acute haemorrhage Malignant disease (e.g. carcinoma, Hodgkin and non-Hodgkin lymphoma) Chronic inflammatory disorders (e.g. rheumatoid arthritis, ulcerative colitis) Acute inflammation Post-operation Splenectomy and hyposplenism Marrow recovery from drug suppression, or…
Time of observation Number of patients Incidence crude Incidence (WSP)a SEER [28] 1998–2000 – – 1.8b 2003–2007 4,653 – 1.7b France [35] 1985–2006 906 – 0.8 Swedish Cancer…
Working groups: NCIWG/IWCLL [2] Parameter Diagnosis Lymphocytes (× 109/L) >5; ≥1 B-cell marker (CD19, CD20, CD23) + CD5 Atypical cells (%) (e.g. prolymphocytes) <55 Duration of lymphocytosis At least…
Ultrasound CT MRI Advantages Low cost Low cost No radiation Availability Availability High contrast resolution Useful for screening and surveillance Quick Liver-specific agents High spatial resolution Functional MRI Highest…
Fig. 1 IL-6/STAT3 signaling pathway. Shown is a schematic figure of the IL-6/JAK/STAT signaling pathway. Binding of IL-6 to its cognate receptor results in phosphorylation of JAK1/2 with subsequent autophosphorylation of…
Tumor classification Definition Stage Criteria T0, N0, M0 Not found Stage I T1 T1 One nodule <2.0 cm Stage II T2 T2 One nodule 2.0–5.0 cm; 2 or 3 nodules, all <3.0 cm Stage III T3 T3…
